NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

ROQU Group

By Mindo - 12th Oct 2020

Pictured at the live demonstration of digital platform Health Passport Ireland and following rapid antigen testing are (l to r): Robert Quirke, CEO of ROQU Group, Prof. Martin Curley, Director of Digital Transformation and Open Innovation at the HSE, Liz Connelly, Infection Prevention & Control Nurse

The ROQU Group recently announced progress in Ireland’s response to the Covid-19 pandemic by completing a live demonstration of the very latest rapid antigen testing technology during the HSE’s Digital Academy Forum.

A first for Ireland, the test was performed live on-air with Prof Martin Curley, Director of Digital Transformation and Open Innovation at the HSE. The results were generated within 15 minutes before the end of Prof Curley’s presentation.

Pictured L-R are: Mr Robert Quirke, CEO of ROQU Group; Prof Curley; and Ms Liz Connelly, Infection Prevention and Control Nurse

Leave a Reply

Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read